Schedule 13G ownership disclosure
BIOCRYST PHARMACEUTICALS INC
Security class unavailable · CUSIP: 09058V103
Event date: 2016-03-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,750,783
- Percent of class
- 5.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-16-087822
- Form type
- SC 13G
- Filer
- BIOCRYST PHARMACEUTICALS INC
- CIK
- CIK 882796
- Filed
- Mar 14, 2016
- Reporting period
- Mar 04, 2016
- Description
- Schedule 13G beneficial ownership